• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用免疫刺激剂短小丙酸杆菌治疗寻常疣。

Treatment of common warts with the immune stimulant Propionium bacterium parvum.

作者信息

Nasser Nilton

机构信息

Universidade Regional de Blumenau, SC, Brazil.

出版信息

An Bras Dermatol. 2012 Jul-Aug;87(4):585-9. doi: 10.1590/s0365-05962012000400011.

DOI:10.1590/s0365-05962012000400011
PMID:22892773
Abstract

BACKGROUND

Warts are epithelial proliferations in the skin and mucous membrane caused by various types of HPV. They can decrease spontaneously or increase in size and number according to the patient's immune status. The Propionium bacterium parvum is a strong immune stimulant and immune modulator and has important effects in the immune system and it is able to produce antibodies in the skin.

OBJECTIVE

To show the efficacy of the Propionium bacterium parvum in saline solution in the treatment of skin warts.

METHODS

A randomized double-blind study. Twenty patients with multiple warts were divided into two groups: one received 0,1 ml intradermal injection of placebo solution in just one of the warts and the other received 0,1 ml of saline solution of Propionium bacterium parvum, one dose a month, for 3 to 5 months.

RESULTS

Among the 20 patients who participated in the study, ten received the placebo and ten received the saline solution with Propionium bacterium parvum. In 9 patients treated with the Propionium bacterium parvum solution the warts disappeared without scars and in 1 patient it decreased in size. In 9 patients who received the placebo no change to the warts was observed and in 1 it decreased in size.

CONCLUSIONS

The immune modulator and immune stimulant Propionium bacterium parvum produced antibodies in the skin which destroyed the warts without scars, with statistically significant results (P<0,001), and cured 90 % of the patients. We suggest the use of the immune stimulant in the treatment of warts.

摘要

背景

疣是由各种类型的人乳头瘤病毒(HPV)引起的皮肤和黏膜上皮增生。它们可根据患者的免疫状态自行消退或增大、增多。短小丙酸杆菌是一种强大的免疫刺激剂和免疫调节剂,在免疫系统中具有重要作用,且能够在皮肤中产生抗体。

目的

展示短小丙酸杆菌生理盐水溶液治疗皮肤疣的疗效。

方法

一项随机双盲研究。20例多发性疣患者被分为两组:一组仅在一个疣内进行0.1 ml皮内注射安慰剂溶液,另一组接受0.1 ml短小丙酸杆菌生理盐水溶液,每月一剂,共3至5个月。

结果

参与研究的20例患者中,10例接受安慰剂,10例接受短小丙酸杆菌生理盐水溶液。接受短小丙酸杆菌溶液治疗的9例患者疣消失且无瘢痕,1例患者疣体积减小。接受安慰剂的9例患者疣无变化,1例患者疣体积减小。

结论

免疫调节剂和免疫刺激剂短小丙酸杆菌在皮肤中产生抗体,可消除疣且无瘢痕,结果具有统计学意义(P<0.001),治愈了90%的患者。我们建议使用这种免疫刺激剂治疗疣。

相似文献

1
Treatment of common warts with the immune stimulant Propionium bacterium parvum.用免疫刺激剂短小丙酸杆菌治疗寻常疣。
An Bras Dermatol. 2012 Jul-Aug;87(4):585-9. doi: 10.1590/s0365-05962012000400011.
2
Efficacy comparison between cimetidine and zinc sulphate in the treatment of multiple and recalcitrant warts.西咪替丁与硫酸锌治疗多发性及顽固性疣的疗效比较
An Bras Dermatol. 2009 Jan-Feb;84(1):23-9. doi: 10.1590/s0365-05962009000100003.
3
[Cimetidine therapy for multiple warts in children].[西咪替丁治疗儿童多发性疣]
Tunis Med. 2002 Apr;80(4):214-6.
4
Cimetidine treatment for viral warts enhances IL-2 and IFN-gamma expression but not IL-18 expression in lesional skin.西咪替丁治疗病毒性疣可增强病变皮肤中IL-2和IFN-γ的表达,但不增强IL-18的表达。
Eur J Dermatol. 2003 Sep-Oct;13(5):445-8.
5
Treatment of multiple viral warts with levamisole.
Int J Dermatol. 1980 Jul-Aug;19(6):342-3. doi: 10.1111/j.1365-4362.1980.tb00355.x.
6
Plantar warts treated with an immune response modifier: a report of two cases.
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:45-7. doi: 10.1046/j.1365-2230.28.s1.15.x.
7
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.外用5%咪喹莫特乳膏自我给药治疗外生殖器肛门疣。人乳头瘤病毒研究小组。人乳头瘤病毒
Arch Dermatol. 1998 Jan;134(1):25-30. doi: 10.1001/archderm.134.1.25.
8
The treatment of resistant warts with intralesional bleomycin: a controlled clinical trial.
Br J Dermatol. 1984 Aug;111(2):197-207. doi: 10.1111/j.1365-2133.1984.tb04044.x.
9
Immunotherapy in viral warts with intradermal Calmette-Guerin vaccine versus intradermal tuberculin purified protein derivative: A double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India.皮内注射卡介苗与皮内注射结核菌素纯蛋白衍生物治疗病毒性疣的免疫疗法:在印度东部一家三级护理中心进行的比较有效性和安全性的双盲随机对照试验。
Indian J Dermatol Venereol Leprol. 2017 May-Jun;83(3):411. doi: 10.4103/0378-6323.193623.
10
Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream.用5%咪喹莫特乳膏对一名HIV阳性患者的寻常疣进行局部治疗。
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:48-50. doi: 10.1046/j.1365-2230.28.s1.16.x.

引用本文的文献

1
COVID-19 vaccine and boosted immunity: Nothing ad interim to do?新冠疫苗与增强免疫力:目前无事可做?
Vaccine. 2020 Nov 10;38(48):7581-7584. doi: 10.1016/j.vaccine.2020.10.013. Epub 2020 Oct 9.
2
The long-standing history of Corynebacterium parvum, immunity, and viruses.短小棒状杆菌的悠久历史、免疫与病毒。
J Med Virol. 2020 Nov;92(11):2429-2439. doi: 10.1002/jmv.26100. Epub 2020 Jun 29.
3
Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.设计和开发疫苗、药物和治疗方法以对抗人类乳头瘤病毒的进展。
Front Immunol. 2018 Nov 12;9:2478. doi: 10.3389/fimmu.2018.02478. eCollection 2018.
4
Evolving role of immunotherapy in the treatment of refractory warts.免疫疗法在难治性疣治疗中的作用演变
Indian Dermatol Online J. 2016 Sep-Oct;7(5):364-370. doi: 10.4103/2229-5178.190487.
5
Immunomodulators in warts: Unexplored or ineffective?疣中的免疫调节剂:未被探索还是无效?
Indian J Dermatol. 2015 Mar-Apr;60(2):118-29. doi: 10.4103/0019-5154.152502.
6
Efficacy of Myrtus communis L. and Descurainia sophia L. Versus Salicylic Acid for Wart Treatment.香桃木和播娘蒿与水杨酸治疗疣的疗效比较
Iran Red Crescent Med J. 2014 Oct 5;16(10):e16386. doi: 10.5812/ircmj.16386. eCollection 2014 Oct.
7
First Case Report: Treatment of the Facial Warts by Using Myrtus communis L. Topically on the Other Part of the Body.首例病例报告:利用香桃木局部外用治疗身体其他部位的面部疣
Iran Red Crescent Med J. 2014 Feb;16(2):e13565. doi: 10.5812/ircmj.13565. Epub 2014 Feb 5.